Here comes Gossamer Bio... - Business Insider

Sean Gallup/Getty Images Gossamer Bio will go public Friday on the Nasdaq. Shares priced at $16 apiece on Thursday evening, raising about $276 million. Gossamer will trade under the ticker "GOSS."  Gossamer Bio priced its initial public offering on Thursday evening.  The clinical-stage biopharmaceutical company that focuses on "discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology" priced its IPO at $16 a share, according to a press release out Thursday evening. The sale of 17.25 million shares will raise about $276 million.  BofA Merrill Lynch, SVB Leerink, Barclays and Evercore ISI were  joint book-running managers for the offering. Gossamer shares will trade on the Nasdaq, under the ticker "GOSS."  Let's block ads! (Why?) via Business - Latest - Google News https://read.bi/2GwNIMl If New feed item from http://ftr.fivefilters.org/makefulltextfeed.php?url=https%3A%2F%2Fnews.google.com%2Frss%2Ftopics%2FCAAqJggKIiBDQkFTRWd Unsubscribe from these notifications or sign in to manage your Email Applets.

Bagikan Berita Ini